Edition:
United States

Insider Trading: CTi Biopharma Corp (CTIC.PH)

CTIC.PH on Philadelphia Stock Exchange

4.38USD
27 Mar 2017
Change (% chg)

-- (--)
Prev Close
$4.38
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
599
52-wk High
$5.88
52-wk Low
$3.20

All Insider Trades
Trading Date Name Title Type Shares Traded Price
10 Jan 2017

Perry Matthew D

Director and Beneficial Owner Buy 8,403 $0.00
30 Dec 2016

Seeley (Bruce J)

Officer Buy 5,000 $0.30
29 Jun 2016

Seeley (Bruce J)

Officer Buy 5,000 $0.29
23 Jun 2016

Bianco (James A)

Chief Executive Officer Sell 10,000 $0.37
26 May 2016

Bianco (James A)

Chief Executive Officer Sell 10,000 $0.45
28 Apr 2016

Mundinger (Mary Oneil)

Director Buy 63,695 $0.00
28 Apr 2016

Nudelman (Phillip M)

Director Buy 79,618 $0.00
28 Apr 2016

Telling (Frederick W)

Director Buy 63,695 $0.00
28 Apr 2016

Bianco (James A)

Chief Executive Officer Sell 10,000 $0.52
28 Apr 2016

Love (Richard L)

Director Buy 63,695 $0.00
28 Apr 2016

Tuckson (Reed Vaughn M.D.)

Director Buy 63,695 $0.00
27 Mar 2016

Bianco (James A)

Chief Executive Officer Sell 10,000 $0.49
20 Mar 2016

Singer (Jack W)

Officer and Director Sell 45,935 $0.55
20 Mar 2016

Bianco (James A)

Chief Executive Officer Sell 318,169 $0.55
20 Mar 2016

Plunkett (Matthew J)

Officer Sell 63,874 $0.55
20 Mar 2016

Bianco (Louis A)

Officer Sell 46,556 $0.55
3 Mar 2016

Plunkett (Matthew J)

Officer Sell 1,300 $0.59
3 Mar 2016

Plunkett (Matthew J)

Officer Sell 700 $0.59
3 Mar 2016

Plunkett (Matthew J)

Officer Sell 400 $0.59
3 Mar 2016

Plunkett (Matthew J)

Officer Sell 1,220 $0.60
3 Mar 2016

Plunkett (Matthew J)

Officer Sell 1,100 $0.59
3 Mar 2016

Plunkett (Matthew J)

Officer Sell 500 $0.59
3 Mar 2016

Plunkett (Matthew J)

Officer Sell 844 $0.59
3 Mar 2016

Plunkett (Matthew J)

Officer Sell 1,500 $0.59
3 Mar 2016

Plunkett (Matthew J)

Officer Sell 636 $0.59

Institutional Holders

% Shares Owned: 24.48%
# of Holders: 67
Total Shares Held: 6,909,461
3 Mo. Net Change: -233,241
# New Positions: 8
# Closed Positions: 10
# Increased Positions: 19
# Reduced Positions: 30
# Net Buyers: -11

Officers & Directors

Name Age Since Current Position

Phillip Nudelman

79 2005 Independent Chairman of the Board

Adam Craig

50 2017 President, Chief Executive Officer, Director

Bruce Seeley

53 2017 Principal Financial Officer, Executive Vice President, Chief Commercial and Administrative Officer, Secretary

Jack Singer

72 2013 Interim Chief Medical Officer, Executive Vice President, Global Medical Affairs and Translational Medicine, and Chief Compliance Officer.

Matthew Plunkett

43 2012 Executive Vice President, Corporate Development

Nancy Boman

Senior Vice President of Clinical Development and Regulatory Affairs

Monique Greer

48 Senior Vice President of Corporate Communications and Investor Relations

Richard Love

73 2017 Director

Michael Metzger

45 2017 Director

Matthew Perry

2016 Director

Frederick Telling

63 2006 Independent Director

Reed Tuckson

65 2011 Independent Director

Ed Bell

Director - Investor Relations